Living long with sickle cell beta thalssemia: a-71-year-old survivor: a case report

Sickle cell disease (SCD) is an inherited hemoglobinopathy associated with reduced life expectancy due to recurrent vaso-occlusive crises, progressive organ damage, and life-threatening infections. Although genotype is a major determinant of disease severity and mortality, advances in preventive strategies and comprehensive care have significantly improved survival. However, survival into the seventh decade remains uncommon in patients with sickle-β-thalassemia. We report the case of a 71-year-old Bahraini male with sickle-β⁺-thalassemia who demonstrated a remarkably mild clinical course over seven decades. This case illustrates that survival in SCD is influenced not only by genotype but also by preventive strategies, adherence to vaccination and penicillin prophylaxis, regular follow-up at specialized SCD centers, and multidisciplinary care. Comprehensive management can substantially modify disease progression and improve long-term outcomes, even in patients with genetically severe forms of SCD.